Hedge Fund ADAR1 Capital Invests $37 Million in Crinetics Pharmaceuticals
ADAR1 Capital Management acquired a stake worth approximately $37.07 million in Crinetics Pharmaceuticals (CRNX) during the first quarter of 2026, according to an SEC filing dated May 15, 2026. The investment increased ADAR1's position by 829,963 shares and raised its stake to 2.44% of the fund’s reportable AUM.
Tickers: $CRNX